Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 3
2010 1
2012 1
2013 1
2017 1
2018 1
2019 2
2020 2
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Polo-like kinases and acute leukemia.
Goroshchuk O, Kolosenko I, Vidarsdottir L, Azimi A, Palm-Apergi C. Goroshchuk O, et al. Among authors: vidarsdottir l. Oncogene. 2019 Jan;38(1):1-16. doi: 10.1038/s41388-018-0443-5. Epub 2018 Aug 13. Oncogene. 2019. PMID: 30104712 Review.
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.
Vidarsdottir L, Azimi A, Das I, Sigvaldadottir I, Suryo Rahmanto A, Petri A, Kauppinen S, Ingvar C, Jönsson G, Olsson H, Frostvik Stolt M, Tuominen R, Sangfelt O, Pokrovskaja Tamm K, Hansson J, Grandér D, Egyházi Brage S, Johnsson P. Vidarsdottir L, et al. Sci Rep. 2021 May 26;11(1):11023. doi: 10.1038/s41598-021-89389-9. Sci Rep. 2021. PMID: 34040017 Free PMC article.
AURKA and breast cancer in BRCA1/2 mutation carriers.
Bodvarsdottir SK, Vidarsdottir L, Eyfjord JE. Bodvarsdottir SK, et al. Among authors: vidarsdottir l. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2517. doi: 10.1158/1055-9965.EPI-07-0669. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 18006949 Free article. No abstract available.
13 results